Dr. Dustin Sulak is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis, the author of Handbook of Cannabis for Clinicians: Principles and Practice, and co-founder of Healer, a medical cannabis education resource and products company. He …
Keeping Up with Cannabinoid Medicine Research with Bonni Goldstein, MD
Bonni Goldstein is one of the country’s most respected and experienced medical cannabis physicians, having treated thousands of patients with medical cannabis. She is the owner and medical director of Canna-Centers Wellness & Education. She is Clinical Advisor to Cannformatics, and she is the author of the book titled “Cannabis is Medicine: How Medical Cannabis and CBD Are Healing Everything from Anxiety …
Improving Longevity with Cannabis Compounds | Hunter Land, PhD
Hunter Land, PhD is the Vice President of Research & Development at Biopharmaceutical Research Company, one of the few DEA Schedule I, FDA compliant cannabinoid research and development companies. He has 20 years of R&D expertise across 25 different indications, as well as 12 years of cannabinoid-focused research. Most notably, he was GW Pharma’s first full-time R&D employee in the US, where …
Performing Clinical Trials on Cannabinoid Products with Jeff Chen, MD
Dr. Jeff Chen is the Co-founder and CEO of Radicle Science, a health tech company generating history’s first dataset and AI to prove and predict the effects of health and wellness products. Previously, he was the Founder and Exec Director of the UCLA Cannabis Research Initiative. At CannMed 2022, Dr. Chen presented results for Radicle Health’s ACES study, a randomized …
Reviewing Research on Cannabis and COVID-19 with Ethan Russo, MD
Dr. Ethan Russo returns to the podcast to help us make sense of the slew of studies and articles claiming cannabis can treat and/or prevent COVID-19 infection. Dr. Russo is a board-certified neurologist, a psychopharmacology researcher, an author, a lecturer, and a consultant. He is a CannMed 2022 Keynote Presenter, where he will present on Cannabis and Psychiatry. Although Dr. …
Safety and Legality of Delta-8 THC with Greg Gerdeman, PhD
Greg Gerdeman, PhD is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system. Recently, Greg has gotten involved in the conversation around Delta-8 THC. He comes at the topic from a neuroscientist’s perspective questioning how much we know about how Delta-8 THC affects the body and the brain. He also raises important questions …
Cannabinoid Hyperemesis Syndrome with Alice Moon
Alice Moon is a PR and marketing professional who has worked in the cannabis space since 2011. In 2018, Alice was diagnosed with Cannabinoid Hyperemesis Syndrome, a condition that leads to repeated and severe bouts of vomiting when she consumes cannabinoids. Since being diagnosed with CHS, Alice has ceased cannabis use completely and become an advocate for safe and mindful …
CBD for Neuropathic Pain Clinical Trial Results with Debra Kimless, MD
Dr. Debra Kimless is the CMO of Pure Green Pharmaceuticals, where she oversees clinical medical testing, patient and physician educational programs, and medical product development. Deb and her team recently published an open-label clinical trial for treating diabetic neuropathic pain with a water-soluble CBD tablet. In our conversation we discuss: Results from her clinical trial for treating diabetic neuropathic pain with …
Endocannabinoid System Deep Dive with Mauro Maccarrone, PhD
Our guest in this episode is Dr. Mauro Maccarrone. Mauro is a pioneer in endocannabinoid research. In 1997, his team identified the receptor targets for the first two endocannabinoids that were discovered by Professor Raphael Mechoulam earlier in the decade: anandamide and 2-AG. Since then, the endocannabinoid system has been the focus of his research. At CannMed 2021 he will present …
CBD for Anxiety Clinical Trial Results with Staci Gruber, PhD
Our guest this week is Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber has spent decades investigating how both recreational and medical cannabis use affects the brain. In 2014, Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND), the …